Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 July 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS


News
What is RSS? RSS

Fecal calprotectin and IBD Fecal calprotectin predicts relapse in patients with inactive IBD
22 July 2016

The latest issue of the Alimentary Pharmacology & Therapeutics examines the prognostic significance of fecal calprotectin in patients with inactive inflammatory bowel disease.

Full Story

Duodenal villous atrophy and celiac disease Ethnic variations in duodenal villous atrophy consistent with celiac disease in the USA
22 July 2016

The latest issue of the Clinical Gastroenterology & Hepatology measures the prevalence of duodenal villous atrophy among patients of different ethnicities throughout the United States.

Full Story

Upper GI lesions at primary diagnosis in IBD <br> Prevalence of upper GI lesions at primary diagnosis in adults with IBD
22 July 2016

August's issue of the Inflammatory Bowel Diseases determines the prevalence of upper gastrointestinal lesions at primary diagnosis in adults with inflammatory bowel disease.

Full Story

<div>Radiofrequency ablation in Barrett's</div>
Adverse events after radiofrequency ablation in patients with Barrett’s 
21 July 2016

August's issue of the Clinical Gastroenterology & Hepatology assessed the rate of adverse events associated with radiofrequency ablation with and without endoscopic mucosal resection

Full Story

<div>HCV eradication and inflammation in cirrhotic patients</div>
HCV eradication does not impact gut dysbiosis in cirrhotic patients
21 July 2016

HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients, reports a study published ahead of print in the Alimentary Pharmacology & Therapeutics.

Full Story
Slide atlas
Selection:
Kaposi's sarcoma in colon
Kaposi's sarcoma in colon
Kaposi's sarcoma in stomach
Kaposi's sarcoma in stomach
Sub Capsular Hepatic Pseudocyst
Sub Capsular Hepatic Pseudocyst

Play a part in the GastroHep.com community by publishing your important images in the Slide Atlas. We're looking for high quality images in gastroenterology, hepatology or endoscopy.

Slide atlas
Selection: (Click on a book cover to buy or find out more)
Book Cover Book Cover Book Cover Book Cover Book Cover Book Cover Book Cover Book Cover Book Cover Book Cover

More books and sample chapters Gastroenterology and Hepatology from Wiley

Go to top of page Email this page Email this page to a colleague

Latest:
Safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy


Treat chronic hepatitis C virus infection in decompensated cirrhosis – pre- or post-liver transplantation? the ironic conundrum in the era of effective and well-tolerated therapy


Safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy


Sarcopenia in cirrhosis – aetiology, implications and potential therapeutic interventions


Recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease


Bile acid diarrhoea – pathogenesis, diagnosis and management

Adenocarcinoma in EIPD by Dr Dennis Nyuk Fung Lim1, Dr Andrew Steel2
Dr Dennis Nyuk Fung Lim<sup>1</sup>, Dr Andrew Steel<sup>2</sup>

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us